Rationale, design and statistical analysis of a prospective randomized trial comparing initially intensified vs standard dose regimens of enteric-coated mycophenolate sodium in De novo renal transplant patients

被引：0
|
作者：
Budde, Klemens [1 ]
Arns, Wolfgang [2 ]
Grandaliano, Giuseppe [3 ]
Kiberd, Bryce [4 ]
Kuypers, Dirk [5 ]
Walker, Rowan [6 ]
机构：
[1] Univ Hosp, Charite, Dept Nephrol, Berlin, Germany
[2] Merheim Med Ctr, Transplant Ctr, Cologne, Germany
[3] Univ Bari, Policlin, Bari, Italy
[4] Dalhousie Univ, Dept Med, Halifax, NS, Canada
[5] Univ Hosp Louvain, Dept Nephrol & Renal Transplantat, Louvain, Belgium
[6] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
来源：
TRANSPLANT INTERNATIONAL | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [21] Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients
    Chadban, Steve
    Eris, Josette
    Russ, Graeme
    Campbell, Scott
    Chapman, Jeremy
    Pussell, Bruce
    Trevillian, Paul
    Ierino, Francesco
    Thomson, Napier
    Hutchison, Brian
    Irish, Ashley
    Woodcock, Chad
    Kurstjens, Nicol
    Walker, Rowan
    [J]. NEPHROLOGY, 2013, 18 (01) : 63 - 70
  • [22] Use of enteric-coated mycophenolate sodium in de novo renal transplant recipients with high incidence of delayed graft function
    Schlavelli, R.
    Gaite, L.
    Carreno, C. Agost
    Baran, M.
    Novoa, P.
    Massari, P.
    Otero, A. B.
    Piulats, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (03) : 905 - 908
  • [23] Adequate Early Mycophenolic Acid (MPA) Exposure Achieved by Initially Intensified Dosing Regimen of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients.
    Arns, W.
    Sommerer, C.
    Tedesco-Silva, H.
    Contieri, F.
    Kuypers, D.
    Vaidya, S.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 395 - 396
  • [24] AN INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM IN RENAL TRANSPLANT PATIENTS RESULTS IN IMPROVED EFFICACY WITHOUT COMPROMISING SAFETY
    Sommerer, C.
    Arns, W.
    Zeier, M.
    Ariatabar, T.
    Glander, P.
    Vogel, E. -M.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 67 - 67
  • [25] Pharmacokinetic and pharmacodynamic comparison of an initially intensified dosing regimen versus a standard dosing regimen of enteric-coated mycophenolate sodium (EC-MPS) in renal transplant patient
    Arns, W.
    Budde, K.
    Glander, P.
    Sommerer, C.
    Ariatabar, T.
    Eichele, K.
    Fischer, W.
    Zeier, M.
    [J]. MEDIZINISCHE KLINIK, 2009, 104 (01): : 93 - 93
  • [26] Pharmacokinetics of enteric-coated mycophenolate sodium in de novo renal transplant patients in combination with tacrolimus: Results of a 6-month stud
    Kaplan, Bruce
    Chan, Laurence
    Messa, Piergiorgio
    Mulgaonkar, Shamkant
    Koelle, Ernst-Ulrich
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 582 - 582
  • [27] INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM ACHIEVES EARLY HIGH DRUG EXPOSURE AND LOWER RATES OF ACUTE REJECTION VERSUS STANDARD DOSING IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Kuypers, D.
    Tedesco Silva, H.
    Budde, K.
    Arns, W.
    Shoker, A.
    Prestele, H.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 251 - 251
  • [28] Efficacy and Safety of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: Results of the ZEUS Trial
    Pietruck, F.
    Becker, T.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 499 - 499
  • [29] The Pharmacokinetics of Enteric-Coated Mycophenolate Sodium and Its Gastrointestinal Side Effects in De Novo Renal Transplant Recipients of Hispanic Ethnicity
    Shah, Tariq
    Tellez-Corrales, Eglis
    Yang, Jae-Wook
    Qazi, Yasir
    Wang, Jeffrey
    Wilson, James
    Hutchinson, Ian
    Min, David I.
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (01) : 45 - 49
  • [30] Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium
    Kamar, N
    Oufroukhi, L
    Faure, P
    Ribes, D
    Cointault, O
    Lavayssiere, L
    Nogier, MB
    Esposito, L
    Durand, D
    Rostaing, L
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) : 2231 - 2236
12345